
NEPHROPLUS
Nephrocare Health Services Limited
- IPO Status
- Closed
- Open Date
- 10 Dec 2025
- Close Date
- 12 Dec 2025
IPO Details
- Min. Investment
- ₹14,720
- Price Band
- ₹438 - ₹460
- Lot Size
- 32 shares
- Issue Size
- ₹871 Cr
- Face Value
- 2
- IPO Doc
- —
Schedule
- IPO open10 Dec 2025
- IPO close date12 Dec 2025
- Allotment date15 Dec 2025
- Funds unblock or debit16 Dec 2025
- Listing date17 Dec 2025
Financial Performance
- Revenue
- Profit
Stocks similar to NEPHROPLUS
- Jupiter Life Line Hospitals Ltd
- Dr Agarwal's Health Care Ltd
- Dr Lal Pathlabs Ltd
- Metropolis Healthcare Ltd
- Vijaya Diagnostic Centre Ltd
FAQs
Nephrocare Health Services Limited IPO is a Mainboard IPO aggregating up to ₹871 Cr, with equity shares of face value ₹2 each. The shares are proposed to be listed on NSE.
The Nephrocare Health Services Limited IPO opened on 10 Dec 2025 and closed on 12 Dec 2025. IPO Period: 10 Dec 2025 – 12 Dec 2025.
The price band for the Nephrocare Health Services Limited IPO is ₹438 to ₹460 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 32 shares. At the upper price band of ₹460, the minimum investment required is ₹14,720.
Particular Details Lot Size 32 shares Price Band ₹438 – ₹460 Minimum Investment ₹14,720 Maximum Retail Lots 13 Here is the timeline for the Nephrocare Health Services Limited IPO:
IPO Event Date IPO Opens 10 Dec 2025 IPO Closes 12 Dec 2025 UPI Mandate Deadline 12 Dec 2025, 5:00 PM Basis of Allotment 15 Dec 2025 Refund Initiation 16 Dec 2025 Shares Credited 16 Dec 2025 Listing Date 17 Dec 2025 The basis of allotment for the Nephrocare Health Services Limited IPO is expected to be finalised on 15 Dec 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: KFin Technologies.
The equity shares of Nephrocare Health Services Limited are proposed to be listed on NSE. Proposed Listing Date: 17 Dec 2025.
The key financial performance of Nephrocare Health Services Limited is:
Financial Year Revenue Profit FY24 ₹566.16 Cr ₹35.13 Cr FY25 ₹755.81 Cr ₹67.1 Cr FY26 ₹998.85 Cr ₹76.84 Cr Revenue CAGR: 32.8% | Profit CAGR: 47.9%. Figures are as disclosed in the company's offer documents.


